期刊
BIOMATERIALS
卷 98, 期 -, 页码 192-202出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2016.04.039
关键词
Peptides; Self-assembly; MMP; Cancer therapy; Morphology transition
资金
- EPSRC
- Cancer Research UK
- Engineering and Physical Sciences Research Council [EP/I004912/1] Funding Source: researchfish
- EPSRC [EP/I004912/1] Funding Source: UKRI
A central challenge in cancer care is to ensure that therapeutic compounds reach their targets. One approach is to use enzyme-responsive biomaterials, which reconfigure in response to endogenous enzymes that are overexpressed in diseased tissues, as potential site-specific anti-tumoral therapies. Here we report peptide micelles that upon MMP-9 catalyzed hydrolysis reconfigure to form fibrillar nano structures. These structures slowly release a doxorubicin payload at the site of action. Using both in vitro and in vivo models, we demonstrate that the fibrillar depots are formed at the sites of MMP-9 over expression giving rise to enhanced efficacy of doxorubicin, resulting in inhibition of tumor growth in an animal model. (C) 2016 The Author(s). Published by Elsevier Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据